Analysis of the effect of delayed percutaneous coronary intervention on acute myocardial infarction
延迟经皮冠脉介入治疗对急性心肌梗死的效果分析

摘要

目的 本文旨在探讨延迟经皮冠状动脉介入治疗对于急性心肌梗死患者临床疗效的影响。方法 选择2024年6月-2025年6月内接收的急性心肌梗死患者80例，通过随机分配的方式，将研究对象分为两组：对照组和观察组，对照组和观察组各40例，其中对照组采取药物溶栓治疗，在对照组治疗基础上，观察组采取延迟经皮冠状动脉介入治疗。比较两组治疗效果。结果 治疗前，两组之间的心功能指标参数及心力衰竭生物标志物浓度没有显著差异（P＞0.05），在接受相应治疗后，观察组不仅在心功能的各项指标上显示出优于对照组的结果，其心力衰竭相关标志物的含量也相对较低；与对照组相比，观察组中不良反应事件的发生率更低（P＜0.05）。结论 延迟经皮冠脉介入治疗可有效改善患者心功能，降低心衰标志物水平和不良事件发生率，有较高实际应用价值。

Abstract

Objective This article aims to explore the impact of delayed percutaneous coronary intervention on the clinical efficacy of patients with acute myocardial infarction.
Methods Eighty patients with acute myocardial infarction who were received between June 2024 and June 2025 were selected. Through random allocation, the research subjects were divided into two groups: the control group and the observation group, with 40 cases in each group. The control group was treated with thrombolytic therapy, and on the basis of the treatment in the control group, the observation group was treated with delayed percutaneous coronary intervention. Compare the therapeutic effects of the two groups.
Results Before treatment, there was no significant difference in the parameters of cardiac function indicators and the concentrations of heart failure biomarkers between the two groups (P > 0.05). After receiving the corresponding treatment, the observation group not only showed better results than the control group in various cardiac function indicators, but also had relatively lower contents of heart failure-related markers. Compared with the control group, the incidence of adverse reaction events in the observation group was lower (P < 0.05).
Conclusion   Delayed percutaneous coronary intervention can effectively improve the cardiac function of patients, reduce the levels of heart failure markers and the incidence of adverse events, and has high practical application value.